• 1

    Higby K, et al.. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol 1994; 171:984989.

  • 2

    Smith NA, Lyons JG, McElrath TF. Protein:creatinine ratio in uncomplicated twin pregnancy. Am J Obstet Gynecol 2010; 203:381.e1381.e4.

  • 3

    Osmundson SS, et al.. Maternal proteinuria in twin compared with singleton pregnancies. Obstet Gynecol 2014; 124:332337.

  • 4

    Reece EA, et al.. Diabetic nephropathy: Pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 1988; 159:5666.

  • 5

    Katz AI, et al.. Pregnancy in women with kidney disease. Kidney Int 1980; 18:192206.

  • 6

    Chen TK, et al.. Renal biopsy in the management of lupus nephritis during pregnancy. Lupus 2015; 24:147154.

  • 7

    American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122:11221131.

    • Search Google Scholar
    • Export Citation
  • 8

    Piccoli GB, et al.. Kidney biopsy in pregnancy: Evidence for counselling? A systematic narrative review. BJOG 2013; 120:412427.

  • 9

    Wide-Swensson D, Strevens H, Willner J. Antepartum percutaneous renal biopsy. Int J Gynaecol Obstet 2007; 98:8892.

  • 10

    Gyamfi-Bannerman C, et al.. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016; 374:13111320.

  • 11

    Wang IK, et al.. Association between hypertensive disorders during pregnancy and end-stage renal disease: A population-based study. CMAJ 2013; 185:207213.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    Vikse BE, et al.. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359:800809.

  • 13

    Berks D, et al.. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 2009; 114:13071314.

  • 14

    Fischer MJ, et al.. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis 2004; 43:415423.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15

    Zhang JJ, et al.. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol 2015; 10:19641978.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16

    Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996; 335:226232.

  • 17

    Piccoli GB, et al.. Pregnancy and chronic kidney disease: A challenge in all CKD stages. Clin J Am Soc Nephrol 2010; 5:844855.

  • 18

    Imbasciati E, et al.. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 2007; 49:753762.

  • 19

    Limardo M, et al.. Pregnancy and progression of IgA nephropathy: Results of an Italian multicenter study. Am J Kidney Dis 2010; 56:506512.

  • 20

    Gotestam Skorpen C, et al.. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016; 75:795810.

    • Crossref
    • Search Google Scholar
    • Export Citation

Glomerular Disease and Pregnancy

  • 1 Jonathan J. Hogan, MD, is an Assistant Professor of Medicine and the Clinical Director of the Glomerular Disease Center at the University of Pennsylvania in Philadelphia, PA. Melissa Rosenstein, MD, is an Assistant Professor of Clinical Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco.
Restricted access
Save